SCHEMBL31673014

SCHEMBL31673014

CNC(=O)c1cnc(N2CCCC2)nc1Nc1ccc(C2CC2)nc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ STK17A Q9UEE5 1/20 0.46
▸ CAMK1D Q8IU85 12/20 0.46
▸ PDE4B Q07343 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ JAK2 O60674 1/20 0.42
▸ JAK1 P23458 1/20 0.42
▸ PTPN11 Q06124 1/20 0.42
▸ PIP5K1C O60331 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ RIPK4 P57078 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42
▸ MAP2K5 Q13163 1/20 0.42
▸ CAMK1 Q14012 1/20 0.42
▸ MAP3K11 Q16584 1/20 0.42
▸ PNCK Q6P2M8 1/20 0.42
▸ CAMK1G Q96NX5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL31673031 0.99 STK17A (0.46) STK17ACAMK1DPDE4BMAPTJAK2
Hydrochloric Acid SCHEMBL30751535 0.91 CAMK1D (0.44) STK17ACAMK1DPDE4BJAK2JAK1
SCHEMBL30751509 0.91 SYK (0.46) STK17ACAMK1DMAPTPTPN11
SCHEMBL31673012 0.91 CAMK1D (0.46) STK17ACAMK1DPDE4BMAPTJAK2
SCHEMBL30751570 0.90 SYK (0.41) STK17ACAMK1DPDE4BJAK2JAK1
SCHEMBL30751577 0.89 CAMK1D (0.48) STK17ACAMK1DPDE4BJAK2JAK1
SCHEMBL31673049 0.88 CAMK1D (0.59) CAMK1DPDE4BJAK2JAK1PIP5K1C
SCHEMBL31673024 0.87 SYK (0.40) CAMK1DJAK2JAK1PIP5K1CCYP2C9
SCHEMBL30751530 0.87 SYK (0.46) CAMK1DJAK1PIP5K1CCYP2C9CYP2C19
SCHEMBL30751494 0.87 SYK (0.46) CAMK1DJAK1PIP5K1CCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257051-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS 1910 GENETICS INC (US) 2025-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257051-A1 SUBSTITUTED PYRIMIDINE COMPOUNDS AS TYK2 INHIBITORS TYK2, PDXK, JAK1 STK17A 54/4885CAMK1D 667/4885PDE4B 4049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback